MARSHALLTOWN, Iowa — The Alcon AcrySof one-piece IOLs perform well, with fewer instances of pseudophakic dysphotopsia than the three-piece AcrySof, according to James Davison, MD. Dr. Davison reviewed ...
FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to ...
DALLAS — The AcrySof foldable acrylic IOL was associated with the fewest complications in a study evaluating the safety and efficacy of several IOLs in uveitic eyes. Mohamed A. Fakhry, MD, spoke about ...
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...
Forty-four eyes of 33 patients underwent routine phacoemulsification cataract surgery with in-the-bag implantation of a toric AcrySof IOLs. Seven eyes were implanted with the SA60T3 IOL, 17 eyes were ...
Alcon, the global leader in eye care and a division of Novartis, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens ...
These results and additional data are being discussed in 11 sessions with world-renowned surgeons at the 41 st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), currently ...
Here is the current list (as of Feb. 9, 2011) of posterior chamber (P-C) and anterior chamber (A-C) intraocular lenses recognized by CMS. – Crystalens, manufactured by Eyeonics (now Bausch & Lomb). – ...
Two human cadaver eyes were prepared in accordance with the Miyake–Apple technique, with closed-system modification. After phacoemulsification, an Acrysof Toric IOL was implanted in the capsular bag.
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results